GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Shanghai United Imaging Healthcare Co 688271.SS · CNY

Health Care · Shanghai · 🇨🇳 China

Compare

118.29

-1.26%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥13.80bn

FY2019FY2025

Net income

CN¥1.87bn

FY2019FY2025

Free cash flow

CN¥585.8m

FY2019FY2025

Shareholders' equity

CN¥21.57bn

FY2019FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
RevenueCN¥13.80bnCN¥10.30bnCN¥11.41bnCN¥9.24bnCN¥7.25bnCN¥5.76bnCN¥2.98bn
Gross profitCN¥6.49bnCN¥5.00bnCN¥5.37bnCN¥4.47bnCN¥3.59bnCN¥2.80bnCN¥1.20bn
Research and developmentCN¥1.84bnCN¥1.76bnCN¥1.73bnCN¥1.31bnCN¥968.4mCN¥755.6mCN¥548.1m
Operating incomeCN¥2.12bnCN¥1.25bnCN¥1.99bnCN¥1.96bnCN¥1.66bnCN¥1.20bn−CN¥35.2m
Net incomeCN¥1.87bnCN¥1.26bnCN¥1.97bnCN¥1.66bnCN¥1.42bnCN¥902.9m−CN¥73.5m
Diluted earnings per share2.271.532.402.011.721.10-0.09

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Total assetsCN¥32.78bnCN¥28.04bnCN¥25.34bnCN¥24.20bnCN¥10.36bnCN¥9.66bn—
Total liabilitiesCN¥11.22bnCN¥8.13bnCN¥6.45bnCN¥6.73bnCN¥5.33bnCN¥6.05bn—
Debt—CN¥684.7mCN¥155.9mCN¥134.4mCN¥321.5mCN¥760.2mCN¥2.07bn
Shareholders' equityCN¥21.57bnCN¥19.90bnCN¥18.87bnCN¥17.48bnCN¥5.04bnCN¥3.60bn—
Shares outstanding824m824m824m824m824m824m824m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operationsCN¥2.68bn−CN¥619.0mCN¥132.5mCN¥682.8mCN¥942.5mCN¥3.31bnCN¥257.5m
Capital spending−CN¥2.09bn−CN¥1.95bn−CN¥1.08bn−CN¥741.3m−CN¥346.7m−CN¥702.6m−CN¥648.7m
Free cash flowCN¥585.8m−CN¥2.56bn−CN¥943.3m−CN¥58.5mCN¥595.7mCN¥2.61bn−CN¥391.1m
Dividends paid−CN¥176.1m−CN¥303.6m−CN¥166.0m−CN¥956,788−CN¥8.1m−CN¥56.7m—

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024
RevenueCN¥4.14bnCN¥2.91bnCN¥4.94bnCN¥3.54bnCN¥2.48bnCN¥3.35bnCN¥1.62bnCN¥2.98bn
Gross profitCN¥1.96bnCN¥1.37bnCN¥2.32bnCN¥1.65bnCN¥1.24bnCN¥1.56bnCN¥749.6mCN¥1.52bn
Operating incomeCN¥670.6mCN¥545.5mCN¥904.6mCN¥662.6mCN¥444.0mCN¥606.5m−CN¥315.6mCN¥595.9m
Net incomeCN¥498.1mCN¥398.9mCN¥749.1mCN¥627.9mCN¥370.1mCN¥590.7m−CN¥279.0mCN¥586.9m
Diluted earnings per share0.600.480.910.760.450.72-0.340.71
Capital spending−CN¥554.0m−CN¥890.0m−CN¥475.0m−CN¥404.0m−CN¥672.0m−CN¥439.0m−CN¥528.0m−CN¥341.0m
Total assetsCN¥34.44bnCN¥33.23bnCN¥32.78bnCN¥28.68bnCN¥28.85bnCN¥28.04bnCN¥26.03bnCN¥26.70bn
Shareholders' equityCN¥22.03bnCN¥21.96bnCN¥21.57bnCN¥20.79bnCN¥20.28bnCN¥19.90bnCN¥19.23bnCN¥19.59bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue14.3%19.1%—
Operating income2.7%12.1%—
Net income4.1%15.7%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin47.7%47.7%48.0%—
Operating margin14.0%16.3%17.6%—
Net margin13.0%15.1%15.7%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022
Price to earnings55.282.557.288.1
Price to sales7.510.19.915.8

Dividends and splits

Per share, in the currency the company pays

Paid for 3 years. Last went ex-dividend on 20 Jul 2026.

FY2026FY2025FY2024FY2023
Paid in the year0.180.210.370.201

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.